Snap, the parent company of Snapchat, has hardware ambitions. That is something which is known to all. The company’s first hardware product, Spectacles, may not have performed as well as it might have hoped but that doesn’t mean Snap is going to give up on these ambitions. If a new report is believed, Snap may have acquired a drone maker, and if that’s true it gives us a hint of what to expect from the company.
Buzzfeed News reports that Snap has acquired Ctrl Me Robotics. It’s a small drone maker that’s based in Los Angeles, California. The report even says that this was a cheap deal for Snap as the company’s purchase price was under $1 million.
It has been rumored for quite some time now that Snap is interested in drones and that its next hardware product might be a drone of some sort. This acquisition goes to show that Snap may not have just a passing interest in drones and that this is something it might be thinking about seriously.
It’s claimed that Ctrl Me Robotics was actually in the process of winding down when it approached Snap for a possible deal. Sources familiar with the deal tell Buzzfeed News that the transaction amount was less than $1 million.
Full Content: Buzzfeed
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas